ImmuCell Corporation Payments to Acquire Productive Assets
ImmuCell Corporation (ICCC) reported Payments to Acquire Productive Assets of $77.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2018-11-13
- ImmuCell Corporation payments to acquire productive assets for the quarter ending 2018-09-30 was $46.00K.
- ImmuCell Corporation payments to acquire productive assets for the quarter ending 2018-06-30 was -$64.00K.
- ImmuCell Corporation payments to acquire productive assets for the quarter ending 2018-03-31 was $95.00K.
- ImmuCell Corporation payments to acquire productive assets for the quarter ending 2016-12-31 was -$4.43K.
- ImmuCell Corporation payments to acquire productive assets for fiscal 2016 was $465.38K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$18.00K derived: sum of 2 quarters · filed 2018-11-13 | $77.00K 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $31.00K 10-Q · filed 2018-08-13 | ||||
| 2018-03-31 | $95.00K 10-Q · filed 2018-05-14 | |||||
| 2017-09-30 | $8.66K 10-Q · filed 2017-11-13 | |||||
| 2016-12-31 | -$4.43K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $97.16K derived: sum of 2 quarters · filed 2018-03-29 | $97.16K derived: sum of 3 quarters · filed 2018-03-29 | $465.38K 10-K · filed 2018-03-29 | $368.22K 10-K · filed 2017-03-30 | |
| 2016-09-30 | $101.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $101.59K derived: sum of 2 quarters · filed 2017-11-13 | $469.81K 10-Q · filed 2017-11-13 | $368.22K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $368.22K 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $368.22K 10-Q · filed 2017-05-11 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |